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Abstract 
Over the four decades, a significant decrease has been observed in age-related mortality caused by cardiovascular 
disease. People in developing countries suffer from CAD at a relatively younger age and about half of MI occurs 
under the age of fifty years. Abuse of anabolic steroids is one of the less common causes of atherosclerosis. In this 
report, a 23-year-old body builder male referred to emergency department (ED) with myocardial infarction (MI) 
following chronic Trenbolone acetate consumption. It seems that a comprehensive history of steroid consump-
tion in young patients referred to ED with the chief complaint of chest pain or its equivalents is necessary in ad-
junct to other cardiac risk factors. 
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Introduction:1 
oronary Artery Disease (CAD) is a leading cause 
of death throughout the world (1). Over the four 
decades, a significant decrease has been ob-
served in age-related mortality caused by cardiovascu-
lar disease (2). people in developing countries suffer 
from CAD at a relatively younger age and about half of 
MI occurs under the age of fifty years (3). Inadequate 
perfusion due to atherosclerosis is a common cause of 
coronary artery stenosis (2). Ischemic chest pain in 
young adults is usually related to hypertrophic cardio-
myopathy, congenital coronary abnormalities, tach-
yarrhythmia, myocarditis, aortic stenosis, dissection, or 
coarctation (4). Age, male sex, hypertension, smoking, 
diabetes, dyslipidemia, and obesity are considered as 
established risk factors for cardiovascular diseases and 
atherosclerosis (5, 6). Abuse of anabolic steroids is one 
of the less common causes of atherosclerosis. These 
agents are used currently to increase protein synthesis 
and muscle growth in athletes (7). Since the use of ana-
bolic steroids has been increased, different types of 
them produced (8). Mostly people start  using the ana-
bolic steroids in school time (9). According to the statis-
tics, 0.9% of men and 0.1% of women use these agents 
during their lifetime (10). In this review, a 23-year-old 
male body builder was reported, with myocardial in-
farction (MI) following use of Trenbolone Acetate. 
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Case report:  
A 23-year-old man was referred to the emergency room 
with epigastric pain since the last day. He was an ath-
lete and his previous medical history was negative. Due 
to the absence of risk factors for heart disease, symp-
tomatic treatment was done for him and his pain de-
creased so that the patient was discharged from the 
emergency department. But, after 3 days the patient 
presented again to ED with the same complaint. The 
pain radiated to the left arm accompanied by nausea. 
After obtaining the accurate history of the patient, it 
was elucidated that he has been using the Trenbolone 
Acetate in his daily diet since last year. The patient's 
vital signs were included blood pressure 130/80 
mmHg, heart rate 105 per minute, respiratory rate 25 
per minute, O2 sat 98% (on room air). In physical ex-
amination, the patient had sweated and the lungs were 
clear on auscultation. S1 and S2 sounds of heart were 
normal and S3 sound was heard, too. The abdomen was 
soft but not tender. 
According to the examination and history of the patient, 
electrocardiogram (ECG) was obtained and showed that 
ST elevation on V1-V6 leads (Figure 1). His portable 
chest radiograph was normal. Cardiac markers (Crea-
tine kinase MB and troponin I) were elevated. Due to 
the unavailability of a heart center for doing an emer-
gency Percutaneous Coronary Intervention (PCI), the 
patient was treated with fibrinolysis (streptokinase). 
Then, the patient was transferred to the cardiac center. 
He was admitted to the cardiology ward and after a 
week, angiography was done for him. The patient’s an-
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scending (LAD) and Left Circumflex (LCX) arteries 
(Figure 2). 
Discussion: 
Anabolic steroids can cause many problems such as 
cardiovascular which includes hypertension, left ven-
tricular hypertrophy, impaired diastolic filling, polycy-
themia and thrombosis (7). The effects of steroids on 
lipid profile include decreasing in High Density Lipo-
protein (HDL), increasing in Low Density Lipoprotein 
(LDL) and total cholesterol. These changes are leaded to 
increase the risk of atherosclerosis in the coronary ar-
teries (11-13). Indirectly, increasing the concentrations 
of LDL due to the abuse of anabolic steroids may lead to 
an increase in sensitivity of platelets (14). Long-term 
effects of these agents can be observed in the cardio-
vascular system, mental health, and increasing the risk 
of neoplasm (15). The mortality rate is higher in abus-
ers of these agents (7). 
Trenbolone acetate is a synthetic anabolic steroid (16) 
often referred to as "Fina" by users, because the inject-
able Trenbolone acetate was originally adapted for use 
by bodybuilders from the dissolution of Finaplix H pel-
lets; it is an ear implant used by cattle ranchers to main-
tain the weight of cattle during shipping to slaughter. 
Trenbolone is a steroid used by veterinarians on live-
stock to increase muscle growth and appetite (17, 18). 
Because these drugs have remarkable effects on bulking 
muscle mass and burning fats, illicit use of them have 
been increased among bodybuilders(18). Therefore, it 
seems to be necessary that a comprehensive history of 
steroid consumption in young patients present to the 
emergency department with the chief complaint of 
chest pain or its equivalents should adjunct to other 
cardiac risk factors.  
Conclusion: 
When young athletes with a history of anabolic drugs 
refer to the emergency department with complaints of 
chest pain, ischemic heart issues must be considered. 
Without the necessary symptoms to exclude ischemic 
heart problems, lower age is not an enough criterion for 
such an exclusion. 
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Figure 1: The 12- lead patient’s Electrocardiogram.  
 
 
Figure 2: Patient’s angiography views. A) Upper arrow:  left 
anterior descending artery (LAD), Lower arrow: left circum-
flex artery (LCX); B) after percutaneous coronary intervention 
(PCI) and stent placement in LAD. 
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